Minovia Therapeutics Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   Therapeutic Effects of a Single Intravenous Infusion (IV) of…Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria · a Diagnosis of Pearson Syndrome (PS)

   Primary completion pushed from Dec 2026 to Dec 2027

   Also in this update: Study completion pushed from Dec 2027 to Dec 2028

   Minovia Therapeutics Ltd.·Phase 2· NCT06017869· Registry history of NCT06017869 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

2. Notable

   Collection of Samples of Bone Marrow Aspiration From…Collection of Samples of Bone Marrow Aspiration From · Myelodysplastic Syndrome

   Primary completion pushed from Dec 31, 2025 to Dec 31, 2027

   Also in this update: Study completion pushed from Mar 1, 2026 to Mar 1, 2028

   Minovia Therapeutics Ltd.·Not specified· NCT06144515· Registry history of NCT06144515 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.